Table 1.
Participant characteristicsa
| Characteristic | Value for groupd |
||
|---|---|---|---|
| HIV− | VL<50 | LTNPs | |
| Age (yr) | 43 (37–50) | 46 (41–50) | 52 (43–58) |
| No. of CD4+ T cells/μl | 789 (554–1,070) | 519 (404–590) | 874 (771–1047) |
| % CD4+ T cells | 45 (41–51) | 30 (21–37) | 44 (40–49) |
| No. of CD8+ T cells/μl | 399 (269–531) | 703 (517–1011) | 703 (562–845) |
| % CD8+ T cells | 22 (19–26) | 41 (33–54) | 35 (26–39) |
| CD4/CD8 cell ratio | 2.15 (1.50–2.36) | 0.79 (0.42–1.12) | 1.26 (1.07–1.61) |
| Plasma HIV RNA (copies/ml) | NAb | <50 | <50 |
| Colon tissue HIV RNAc (copies/mg) | NA | <50 | <50 |
| Nadir CD4+ T cells/μl | NA | 184 (35–241) | 720 (639–829) |
a
Median values with IQR in parentheses.
b
NA, not applicable.
c
Tissue HIV RNA was available for only 18 of the VL < 50 and 13 of the LTNP participants.
d
For HIV− group, n = 18; for VL<50 group, n = 22; for LNTPs, n = 14.